PLGA:Poloxamer and PLGA:Poloxamine Blend Nanoparticles: New Carriers for Gene Delivery
- 4 December 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 6 (1) , 271-278
- https://doi.org/10.1021/bm049577p
Abstract
The main objective of the present work was the development of new nanoparticulate carrier systems for the delivery of plasmid DNA. These new carriers consist of a blend matrix formed by a poly(lactic-co-glycolic acid) (PLGA) copolymer and polyoxyethylene derivatives. More specifically, we have prepared nanostructures with different PLGA:poloxamer and PLGA:poloxamine compositions by an optimized emulsification−solvent diffusion technique and studied the potential of these carriers for the encapsulation and controlled release of plasmid DNA. Depending on the particle composition, the encapsulation efficiency of the model plasmid pEGFP−C1 varied between 30% and 45%. All formulations provided continuous and controlled release of the plasmid with minimal burst effect. In addition, the release rate and duration was dependent on the composition of the particle matrix. Moreover, gel electrophoresis and cell culture (MCF-7 cell line) assays allowed us to confirm that the biologically active form of the plasmid was preserved during the particle preparation process and also during its release. Cell culture experiments also indicated that the new nanoparticles do not exhibit toxic effects on these cells at concentrations up to 5 mg/mL. Altogether, these results indicate that these composite nanostructures present a promising approach for the delivery of plasmid DNA.Keywords
This publication has 26 references indexed in Scilit:
- PLA‐PEG nanospheres: new carriers for transmucosal delivery of proteins and plasmid DNAPolymers for Advanced Technologies, 2002
- Shear‐Induced Degradation of Plasmid DNAJournal of Pharmaceutical Sciences, 2002
- Microparticle-mediated Transfection of Non-phagocytic Cells In VitroJournal of Drug Targeting, 2002
- Sustained delivery and expression of DNA encapsulated in polymeric nanoparticlesGene Therapy, 2000
- A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscleGene Therapy, 2000
- Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheresInternational Journal of Pharmaceutics, 1999
- PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilizationJournal of Pharmaceutical Sciences, 1999
- Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactantsEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Poly(?-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administrationVaccine, 1997
- Drug Delivery from Bioerodible PolymersPublished by American Chemical Society (ACS) ,1994